Antagonists of specific excitatory amino acid receptors as neuroprotectants and anxiolytics
US5049555A · kind A · utility
15Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 1988 |
| Grant date | Sep 17, 1991 |
| Priority date | — |
| Expiry date | Dec 19, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/66
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention pertains to a method and pharmaceutical compositions for treating, preventing or reducing neurodegeneration associated with chronic central nervous system or hypoxic, ischemic and hypoglycemic injury to the central nervous system and for the treatment of anxiety through the use of 2-amino-.omega.-phosphonoalkanoic acids having a cycloalkyl group bridging adjacent carbons on the alkyl chain, their pharmaceutically acceptable salts and derivatives as neuroprotectants and anxiolytics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.